Access to new antibacterials in 10 Asian countries: An Asian network for surveillance of resistant pathogens study
- 6 March 2026
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67 (6) , 107769
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050The Lancet, 2024
- Sulbactam/Durlobactam: First ApprovalDrugs, 2023
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Clinical Microbiology and Infection, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfectionsClinical Infectious Diseases, 2021
- European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adultsClinical Microbiology and Infection, 2021
- Harmonising regulatory approval for antibiotics in childrenThe Lancet Child & Adolescent Health, 2021
- Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trialsThe Lancet Infectious Diseases, 2019
- Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community settingInfection Control & Hospital Epidemiology, 2018
- Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysisAmerican Journal of Infection Control, 2014